FAYETTEVILLE, Ark. - Marylandian -- Lineus Medical announces that SafeBreak® Vascular has been added to Alliant Purchasing's contract portfolio, expanding access to the breakaway IV technology across Alliant's extensive healthcare network. Alliant represents more than 280 hospitals and over 68,000 non-acute healthcare facilities across all 50 states. This agreement enables Alliant members to procure SafeBreak Vascular through streamlined contracting, supporting supply chain efficiency while bringing clinically proven IV complication reduction to a broader patient population.

SafeBreak Vascular is a breakaway device for IV lines clinically proven to reduce IV complications.¹ When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. Patients avoid additional needlesticks, nurses save time, and hospitals save money.¹

More on Marylandian

• U.S. Government Contracts in Excess of 38 Million Secured Through Partner, Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
• New Report Reveals Surprising Trends in Ohio Airport Accidents
• Why Your Berberine Failed: RevGenetics Unveils the Absorption Gap Solution
• WCC Kitchens and Cabinets Featured on Selling Houses Australia
• Cat Hunt Simulator : Burrow & Pounce Lands on the App Store

"Joining the Alliant portfolio strengthens our ability to serve healthcare systems at scale," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "Group purchasing organizations(GPO) like Alliant play a critical role in helping hospitals evaluate and adopt innovative technologies while optimizing their supply chain operations. This contract provides a clear procurement pathway for Alliant members and supports our commercial growth as we continue expanding SafeBreak's presence in hospitals nationwide."

"The addition of SafeBreak to the Alliant GPO contract is a significant step forward in our mission to remove the pains associated with IV lines," said Vance Clement, CEO of Lineus Medical. "This agreement means that thousands of healthcare facilities across the country now have simplified access to SafeBreak."

The Alliant contract adds to Lineus Medical's growing presence in the group purchasing space, providing healthcare facilities with accessible options for adopting SafeBreak Vascular as part of their IV protocols.

More on Marylandian

• Shincheonji Marks 42nd Anniversary: From a Basement to a Denomination Growing by Tens of Thousands Annually
• Jackets for Jobs Hosts Smart & Sexy® Day Detroit for Women's History Month
• Tint Academy Training in Dallas Texas: Learn Window Tint & PPF Installation
• $IBG accelerates toward transformative merger with BlockFuel as $6 million raise fuels dual-industry growth strategy: N A S D A Q: IBG
• High-Growth Power Infrastructure Play Targets AI Boom: 1606 Corp. Executes Aggressive Texas Expansion Strategy: 1606 Corp. (Stock Symbol: CBDW) $CBDW

About Lineus Medical:

Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.

About Alliant Purchasing:

Alliant Purchasing is a creative, value-focused, and progressive healthcare improvement partner that has been serving providers nationwide for over 35 years. With a commitment to operational and financial innovation, Alliant empowers members to navigate today's healthcare landscape through simplified supply chain strategies and impactful margin improvement opportunities. Leveraging more than $84 billion in buying power, Alliant supports over 280 hospitals and 68,000 provider locations. Learn more at www.alliantpurchasing.com.

References:

1. Data on file.